EDIT vs GM · rev $32.3M vs P/E 7.5, rev $185.02B
Editas Medicine Inc (EDIT) versus General Motors Company (GM) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
General Motors Company (GM) is a auto manufacturers company listed on US. It is led by Mary Barra.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported GM revenue for 2025-12-31 was $185.02B. Net income was $2.70B. Revenue was down 1.3% from 2024-12-31 to 2025-12-31. GM currently screens at market cap $51.33B and trailing P/E 7.5.
EDIT currently screens at market cap $375.2M. GM currently screens at market cap $51.33B and trailing P/E 7.5.
Not investment advice. Open the EDIT and GM stock pages for the full models.
Not investment advice.